Abstract
Pancreatic carcinoma has high mortality rates, usually associated with late diagnosis. The identification of biomarkers and molecular mechanisms associated with pancreatic tumorigenesis may be useful for the development of directed treatment, which will ultimately lead to improved patient prognosis. In fact, the identification of biomarkers and molecular pathways has led to the developmen…